After two years of underperformance, most home builders remain profitable and many stocks are trading at relatively low ...

During the volatile first quarter of 2026, the Lazard International Equity Portfolio rose 0.3% (net of fees), outperforming ...

The FDA has approved Shionogi's Xocova (ensitrelvir) for post-exposure prevention of Covid-19 in adults and adolescents aged ...

The FDA on Monday approved the first medication for COVID-19 prevention that people can take after they have been exposed to ...

The world is getting more uptight about lending money to President Donald Trump’s government. The energy price spike triggered by the Iran war has seeped into the price of bonds ...

WASHINGTON (AP) — The rise of remote work since the pandemic has made businesses more reluctant to hire young, inexperienced ...

Red Cross workers talk to a woman in Bunia, Democratic Republic of Congo, to raise awareness about Ebola on Monday. (Reuters) ...

The FDA approved the oral antiviral agent ensitrelvir (Xocova) to help prevent COVID-19 in people ages 12 years or older who were exposed to the SARS-CoV-2 virus, drugmaker Shionogi announced.

After soaring in the wake of the covid pandemic, real estate prices globally have been cooling down. The trickle-down effects ...

Minneapolis Fed President Neel Kashkari said this week that ultimately, the Fed could undertake a series of rate hikes if inflation pressures related to the turmoil in the Middle East persist with ...

Japan’s population fell by more than 3 million over the past five years, a record drop that underscores the depths of the country’s accelerating demographic crisis.

AstraZeneca’s IMFINZI ® (durvalumab) in combination with Bacillus Calmette-Guérin (BCG) induction and maintenance therapy has been approved in the US for the treatment of adult patients with BCG-naïve ...